Biocomposites adds Mexico to its list of countries where STIMULAN is approved as an antibiotic carrier for use in bone and soft tissue
STIMULAN® gives surgeons the freedom to choose and combine the antibiotics that support their infection treatment strategy
Keele, UK, 29 November 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce that STIMULAN® has received a new broad-based approval as an antibiotic carrier for use in bone and soft tissue in Mexico. The approval, granted by COFEPRIS, the Mexican Regulatory Authority, authorises the use of STIMULAN as a carrier of substances such as antibiotics that are chosen by the surgeon as part of their infection treatment strategy.
